If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Wiley-Blackwell

Related content
Volume 14, Number 9, 1 September 2012

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

Comparison between sitagliptin as add‐on therapy to insulin and insulin dose‐increase therapy in uncontrolled Korean type 2 diabetes: CSI study
pp. 795-802(8)
Authors: Hong, E. S.; Khang, A. R.; Yoon, J. W.; Kang, S. M.; Choi, S. H.; Park, K. S.; Jang, H. C.; Shin, H.; Walford, G. A.; Lim, S.

Favourites:Add to Favourites

Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis
pp. 803-809(7)
Authors: Pantalone, K. M.; Kattan, M. W.; Yu, C.; Wells, B. J.; Arrigain, S.; Jain, A.; Atreja, A.; Zimmerman, R. S.

Favourites:Add to Favourites

Utility of non‐high‐density lipoprotein cholesterol in assessing incident type 2 diabetes risk
pp. 821-825(5)
Authors: Ley, S. H.; Harris, S. B.; Connelly, P. W.; Mamakeesick, M.; Gittelsohn, J.; Wolever, T. M.; Hegele, R. A.; Zinman, B.; Hanley, A. J.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady‐state conditions in type 1 diabetes
pp. 859-864(6)
Authors: Heise, T.; Hermanski, L.; Nosek, L.; Feldman, A.; Rasmussen, S.; Haahr, H.

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more